Roche : New Format and E-Mail Address for Roche Investor Updates

Investor Update New Format and E-Mail Address for Roche Investor Updates

This is to inform you that, as of 20 July 2020, Roche will send its Investor Updates from a new e-mail account with a new format as a joint-release with our Media Relations department.

Please make sure the following e-mail addresses are added to your 'safe sender' list:
[e-mail] and [e-mail].

Do not hesitate to contact us if you have any questions.

With best regards,

Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Jon Kaspar Bayard Phone: [phone] e-mail: [e-mail]
Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]	Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]
Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]	Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]	Dr. Lisa Tuomi Phone: [phone] e-mail: [e-mail]

Attachment

• 200706_IR_change_e-mail_en